Canada
· Delayed Price · Currency is CAD Satellos Bioscience Statistics
Total Valuation
TSX:MSCL has a market cap or net worth of CAD 106.13 million. The enterprise value is 36.27 million.
| Market Cap | 106.13M |
| Enterprise Value | 36.27M |
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:MSCL has 165.82 million shares outstanding. The number of shares has increased by 32.84% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 165.82M |
| Shares Change (YoY) | +32.84% |
| Shares Change (QoQ) | +6.61% |
| Owned by Insiders (%) | 11.23% |
| Owned by Institutions (%) | 1.91% |
| Float | 138.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.56 |
| P/TBV Ratio | 1.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.29 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.45 |
Financial Position
The company has a current ratio of 14.16
| Current Ratio | 14.16 |
| Quick Ratio | 13.67 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -51.78% and return on invested capital (ROIC) is -32.03%.
| Return on Equity (ROE) | -51.78% |
| Return on Assets (ROA) | -29.63% |
| Return on Invested Capital (ROIC) | -32.03% |
| Return on Capital Employed (ROCE) | -40.98% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.76M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +44.44% in the last 52 weeks. The beta is 0.70, so TSX:MSCL's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | +44.44% |
| 50-Day Moving Average | 0.75 |
| 200-Day Moving Average | 0.70 |
| Relative Strength Index (RSI) | 44.58 |
| Average Volume (20 Days) | 138,202 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -19.60M |
| Operating Income | -27.81M |
| Pretax Income | -28.10M |
| Net Income | -28.10M |
| EBITDA | -27.79M |
| EBIT | -27.81M |
| Earnings Per Share (EPS) | -0.24 |
Balance Sheet
The company has 69.85 million in cash and n/a in debt, giving a net cash position of 69.85 million or 0.42 per share.
| Cash & Cash Equivalents | 69.85M |
| Total Debt | n/a |
| Net Cash | 69.85M |
| Net Cash Per Share | 0.42 |
| Equity (Book Value) | 67.86M |
| Book Value Per Share | 0.41 |
| Working Capital | 67.86M |
Cash Flow
In the last 12 months, operating cash flow was -24.98 million and capital expenditures -6,000, giving a free cash flow of -24.98 million.
| Operating Cash Flow | -24.98M |
| Capital Expenditures | -6,000 |
| Free Cash Flow | -24.98M |
| FCF Per Share | -0.15 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSX:MSCL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -32.84% |
| Shareholder Yield | -32.84% |
| Earnings Yield | -26.48% |
| FCF Yield | -23.54% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |